Table 3.
Groups before and after treatment with regard to symptom (VSS), disability (DHI), and attack frequency.
| Venlafaxine |
Flunarizine |
Valproic acid |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | p | Before | After | p | Before | After | p | |
| VSS | 5.96 (1.72) | 3.78 (1.28) | 0 | 6.41 (1.99) | 5.86 (1.55) | 0.03 | 5.8 (1.82) | 5.3 (1.08) | 0.27 |
| DHI-e | 14.17 (6.95) | 9.39 (5.03) | 0 | 16.91 (6.84) | 15.45 (7.07) | 0.115 | 16.8 (4.7) | 15.3 (4.91) | 0.11 |
| DHI-f | 14.87 (7.11) | 11.57 (5.36) | 0.01 | 16.64 (5.57) | 13.45 (6.24) | 0.013 | 16.60 (5.20) | 13.2 (4.96) | 0.02 |
| DHI-p | 12.61 (4.80) | 9.91 (5.24) | 0.018 | 13.00 (4.44) | 10.91 (4.69) | 0.041 | 13.4 (4.45) | 10.30 (4.91) | 0.01 |
| DHI-t | 41.74 (16.90) | 31.3 (14.14) | 0.001 | 46.64 (15.15) | 39.82 (16.35) | 0.019 | 46.80 (13.45) | 38.7 (13.58) | 0.02 |
| Frequency | 5.83 (3.2) | 3.09 (1.68) | 0 | 4.95 (3.28) | 4.15 (2.46) | 0.057 | 5.1 (3.14) | 2.35 (1.79) | 0 |
Values are expressed as the median (SD).
VSS, Vertigo Severity Score; DHI-t, Dizziness Handicap Inventory-total score; e, emotional; f, functional; p, physical; DHI, Dizziness Handicap Inventory.